PAYAL TAILOR: Open Payments
NPI 1538938949 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $349 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| Madrigal Pharmaceuticals | 1 | $40 |
| Janssen Biotech, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
Products named: RINVOQ, SKYRIZI, REZDIFFRA, TREMFYA, ENTYVIO, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
